Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cero Therapeutics
company
About
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
Cero Therapeutics has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Mar 18, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 18, 2020 | Series A | $40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Cero Therapeutics is funded by 2 investors.
Lyell Immunopharma
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lyell Immunopharma
|
— | Series A |
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
